Average Co-Inventor Count = 4.39
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Regeneron Pharmaceuticals, Inc. (9 from 1,350 patents)
9 patents:
1. 12496470 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments
2. 12251440 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments
3. 11999799 - Anti-TMPRSS2 antibodies and antigen-binding fragments
4. 11773156 - Anti-hemagglutinin antibodies and methods of use thereof
5. 11752214 - Protein-antiviral compound conjugates
6. 11732030 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments
7. 10975139 - Anti-SARS-CoV-2-Spike glycoprotein antibodies and antigen-binding fragments
8. 10954289 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments
9. 10787501 - Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments